News
September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.
September 10, 2007
Feature | Peter Fail, M.D.
More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.
September 10, 2007News
September 11, 2007 - Stereotaxis Inc. said more than 10,000 procedures have been performed using the Stereotaxis system, which utilizes advanced, magnet-guided navigational technology intended to help electrophysiologists and cardiologists treat complex arrhythmias and safely perform other interventional procedures.
September 10, 2007Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025
Feature
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.
September 09, 2007News
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
September 09, 2007Feature | Cristen C. Bolan
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.
September 09, 2007Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
September 09, 2007News
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
September 09, 2007
Feature | Melissa Allen
According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...
September 09, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...
September 09, 2007
Technology
Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...
September 06, 2007
Technology
Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
September 06, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...
September 06, 2007
Technology
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
September 05, 2007News
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...
September 05, 2007